NVIV Financials 07/16/2014 16:27:36 InVivo Therap

NVIV Financials 07/16/2014 16:27:36
InVivo Therapeutics Holdings Corp
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development 10,533 6,376 4,103 1,673
Sales, General and Admin. 8,472 6,404 4,556 1,724
Non-Recurring Items - - - -
Other - - - -
Operating Income (19,005) (12,779) (8,659) (3,397)
Income From Continuing Operations
Add'l Income/Expense Items (19,621) 17,515 (26,057) (3,949)
Earnings Before Interest and Tax (38,626) 4,735 (34,716) (7,347)
Interest Expense 130 72 13 564
Earnings Before Tax (38,756) 4,664 (34,728) (7,911)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (38,756) 4,664 (34,728) (7,911)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (38,756) 4,664 (34,728) (7,911)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (38,756) 4,664 (34,728) (7,911)